MILNACIPRAN ARROW 50 mg, hard capsule 56 capsules, CIP 3400941714313
Active ingredients: Milnacipran hydrochloride, Milnacipran
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule56 capsules, CIP 3400941714313orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MILNACIPRAN ARROW 50 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 56 gélule(s)
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Dec 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67587245CIP74171431CIP133400941714313Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MILNACIPRANgélule | 43,55 mg · une gélule | FT |
| CHLORHYDRATE DE MILNACIPRANgélule | 50 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.